Search bioRxiv⌕ Search

Biology subjects

Glass, E. M.

Publications and source records attributed to Glass, E. M..

6 recordsLinked to original sources

A systems biology approach to evaluate potential probioticcandidates for womens vaginal health

Probiotic supplements are marketed for diverse health benefits, yet species inclusion often lacks functional rationale. We surveyed 352 U.S. probiotic products and found 36 unique microbial species, with most supplements containing only one species and no clear link between species and intended health benefit. To evaluate probiotic function, we developed CoPaPro, a collection of 1,012 genome-scale metabolic models spanning commensal, pathogenic, and probiotic bacteria. Flux balance analysis revealed that current probiotic species fail to capture the metabolic diversity of native commensals. Focusing on vaginal health, we identified commensals with metabolic profiles overlapping Gardnerella vaginalis, a key pathobiont. In vitro spent media assays using 11 vaginal isolates showed variable inhibition of G. vaginalis, primarily driven by D-lactic acid production rather than metabolic similarity. Several non-Lactobacillus species produced inhibitory levels of D-lactate. These findings highlight the need for function-based probiotic design and demonstrate a scalable framework integrating metabolic modeling with experimental validation.

systems biology↗

Model-driven characterization of functional diversity of Pseudomonas aeruginosa clinical isolates with broadly representative phenotypes

Pseudomonas aeruginosa is a leading cause of infections in immunocompromised individuals and in healthcare settings. This study aims to understand the relationships between phenotypic diversity and the functional metabolic landscape of P. aeruginosa clinical isolates. To better understand the metabolic repertoire of P. aeruginosa in infection, we deeply profiled a representative set from a library of 971 clinical P. aeruginosa isolates with corresponding patient metadata and bacterial phenotypes. The genotypic clustering based on whole-genome sequencing of the isolates, multi-locus sequence types, and the phenotypic clustering generated from a multi-parametric analysis were compared to each other to assess the genotype-phenotype correlation. Genome-scale metabolic network reconstructions were developed for each isolate through amendments to an existing PA14 network reconstruction. These network reconstructions show diverse metabolic functionalities and enhance the collective P. aeruginosa pangenome metabolic repertoire. Characterizing this rich set of clinical P. aeruginosa isolates allows for a deeper understanding of the genotypic and metabolic diversity of the pathogen in a clinical setting and lays a foundation for further investigation of the metabolic landscape of this pathogen and host-associated metabolic differences during infection. Impact statementPseudomonas aeruginosa is a leading cause of infections in immunocompromised individuals and in healthcare settings. The treatment of these infections is complicated by the presence of a variety of virulence mechanisms and metabolic uniqueness among clinically relevant strains. This study is an attempt to understand the relationships between isolate phenotypic diversity and the functional metabolic landscape within a representative group of P. aeruginosa clinical isolates. Characterizing this rich set of clinical P. aeruginosa isolates allows for a deeper understanding of genotypic and metabolic diversity of the pathogen in a clinical setting and lays a foundation for further investigation of the metabolic landscape of this pathogen and host-associated metabolic differences in infection.

systems biology↗

Physiological niche informs evolution of metabolic function and corresponding drug targets of pathobionts

Treatment of infections with traditional antimicrobials has become difficult due to the growing antimicrobial resistance crisis, necessitating the development of innovative approaches for deeply understanding pathogen function. Here, we generated a collection of genome-scale metabolic network reconstructions to gain insight into evolutionary drivers of metabolic function. We determined physiological location is a major driver of evolution of metabolic function. We observed that stomach-associated pathobionts had the most unique metabolic phenotypes and identified three essential genes unique to stomach pathobionts across diverse phylogenetic relationships. We demonstrate that inhibition of one such gene, thyX, inhibited growth of stomach- specific pathobionts exclusively, indicating possible physiological niche-specific targeting. This pioneering approach is the first step to using unique metabolic signatures to inform targeted antimicrobial therapies. One sentence summaryA data-driven approach to drug target discovery through metabolic signatures of diverse pathogens conserved across body-sites.

systems biology↗

Reconstructor: A COBRApy compatible tool for automated genome-scale metabolic network reconstruction with parsimonious flux-based gap-filling

SummaryGenome-scale metabolic network reconstructions (GENREs) are valuable for understanding cellular metabolism in silico. Several tools exist for automatic GENRE generation. However, these tools frequently (1) do not readily integrate with some of the widely-used suites of packaged methods available for network analysis, (2) lack effective network curation tools, and (3) are not sufficiently user-friendly. Here, we present Reconstructor, a user-friendly COBRApy compatible tool with ModelSEED namespace compatibility and a pFBA-based gap-filling technique. We demonstrate how Reconstructor readily generates high-quality GENRES that are useful for further biological discovery. Availability and ImplementationThe Reconstructor package is freely available for download via pip in the command line (pip install reconstructor). Usage instructions and benchmarking data are available at http://github.com/emmamglass/reconstructor. ContactJason Papin: papin@virginia.edu

bioinformatics↗

Metabolic network models of Gardnerella pangenome identify interactions in the vaginal environment

Gardnerella is the primary pathogenic bacterial genus present in the polymicrobial infection known as bacterial vaginosis (BV). Despite BVs high prevalence and associated chronic and acute womens health impacts, the Gardnerella pangenome is largely uncharacterized at both the genetic and functional metabolic level. Here, we used genome scale metabolic models to characterize in silico the Gardnerella pangenome metabolic content and assessed metabolic functional capacity within a BV positive cervicovaginal fluid context. Metabolic capacity varied widely across the pangenome, with 38.15% of all reactions as core to the genus, compared to 49.6% of reactions identified as unique to a smaller subset of species. Four genes - gpsA, fas, suhB, psd - were identified as core essential genes, critical for in silico metabolic function of all analyzed bacterial species in the Gardnerella genus. Further understanding of these core essential metabolic functions could inform novel therapeutic strategies to treat BV. These data represent the first metabolic modelling of the Gardnerella pangenome and illustrate strain-specific interactions with the vaginal metabolic environment across the pangenome.

systems biology↗

The DOE Systems Biology Knowledgebase (KBase)

The U.S. Department of Energy Systems Biology Knowledgebase (KBase) is an open-source software and data platform designed to meet the grand challenge of systems biology -- predicting and designing biological function from the biomolecular (small scale) to the ecological (large scale). KBase is available for anyone to use, and enables researchers to collaboratively generate, test, compare, and share hypotheses about biological functions; perform large-scale analyses on scalable computing infrastructure; and combine experimental evidence and conclusions that lead to accurate models of plant and microbial physiology and community dynamics. The KBase platform has (1) extensible analytical capabilities that currently include genome assembly, annotation, ontology assignment, comparative genomics, transcriptomics, and metabolic modeling; (2) a web-browser-based user interface that supports building, sharing, and publishing reproducible and well-annotated analyses with integrated data; (3) access to extensive computational resources; and (4) a software development kit allowing the community to add functionality to the system.

bioinformatics↗